Global Rivaroxaban Market Growth 2021-2026
  • ID: 100529
  • February 4, 2021
  • 137 pages
  • LP Information

According to this latest study, the 2020 growth of Rivaroxaban will have significant change from previous year. By the most conservative estimates of global Rivaroxaban market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 6758.4 million in 2019. Over the next five years the Rivaroxaban market will register a 8.5% CAGR in terms of revenue, the global market size will reach US$ 9368.4 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
2.5 mg
10 mg
15 mg
20 mg

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bayer
J&J

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rivaroxaban Consumption 2016-2026
2.1.2 Rivaroxaban Consumption CAGR by Region
2.2 Rivaroxaban Segment by Type
2.2.1 2.5 mg
2.2.2 10 mg
2.2.3 15 mg
2.2.4 20 mg
2.3 Rivaroxaban Sales by Type
2.3.1 Global Rivaroxaban Sales Market Share by Type (2016-2021)
2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2016-2021)
2.3.3 Global Rivaroxaban Sale Price by Type (2016-2021)
2.4 Rivaroxaban Segment by Application
2.4.1 Acute Coronary Syndrome (ACS)
2.4.2 Venous Thromboembolism (VTE)
2.5 Rivaroxaban Sales by Application
2.5.1 Global Rivaroxaban Sale Market Share by Application (2016-2021)
2.5.2 Global Rivaroxaban Revenue and Market Share by Application (2016-2021)
2.5.3 Global Rivaroxaban Sale Price by Application (2016-2021)

3 Global Rivaroxaban by Company
3.1 Global Rivaroxaban Sales Market Share by Company
3.1.1 Global Rivaroxaban Sales by Company (2019-2021)
3.1.2 Global Rivaroxaban Sales Market Share by Company (2019-2021)
3.2 Global Rivaroxaban Revenue Market Share by Company
3.2.1 Global Rivaroxaban Revenue by Company (2019-2021)
3.2.2 Global Rivaroxaban Revenue Market Share by Company (2019-2021)
3.3 Global Rivaroxaban Sale Price by Company
3.4 Global Manufacturers Rivaroxaban Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rivaroxaban Product Location Distribution
3.4.2 Players Rivaroxaban Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Rivaroxaban by Region
4.1 Global Rivaroxaban by Region
4.1.1 Global Rivaroxaban Sales by Region
4.1.2 Global Rivaroxaban Revenue by Region
4.2 Americas Rivaroxaban Sales Growth
4.3 APAC Rivaroxaban Sales Growth
4.4 Europe Rivaroxaban Sales Growth
4.5 Middle East & Africa Rivaroxaban Sales Growth

5 Americas
5.1 Americas Rivaroxaban Sales by Country
5.1.1 Americas Rivaroxaban Sales by Country (2016-2021)
5.1.2 Americas Rivaroxaban Revenue by Country (2016-2021)
5.2 Americas Rivaroxaban Sales by Type
5.3 Americas Rivaroxaban Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Rivaroxaban Sales by Region
6.1.1 APAC Rivaroxaban Sales by Region (2016-2021)
6.1.2 APAC Rivaroxaban Revenue by Region (2016-2021)
6.2 APAC Rivaroxaban Sales by Type
6.3 APAC Rivaroxaban Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Rivaroxaban by Country
7.1.1 Europe Rivaroxaban Sales by Country (2016-2021)
7.1.2 Europe Rivaroxaban Revenue by Country (2016-2021)
7.2 Europe Rivaroxaban Sales by Type
7.3 Europe Rivaroxaban Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Rivaroxaban by Country
8.1.1 Middle East & Africa Rivaroxaban Sales by Country (2016-2021)
8.1.2 Middle East & Africa Rivaroxaban Revenue by Country (2016-2021)
8.2 Middle East & Africa Rivaroxaban Sales by Type
8.3 Middle East & Africa Rivaroxaban Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Rivaroxaban Distributors
10.3 Rivaroxaban Customer

11 Global Rivaroxaban Market Forecast
11.1 Global Rivaroxaban Forecast by Region
11.1.1 Global Rivaroxaban Forecast by Regions (2021-2026)
11.2.2 Global Rivaroxaban Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Rivaroxaban Forecast by Type
11.7 Global Rivaroxaban Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Bayer Bayer Company Information
12.1.2 Bayer Rivaroxaban Product Offered
12.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bayer Main Business Overview
12.1.5 Bayer Latest Developments
12.2 J&J
12.2.1 J&J Company Information
12.2.2 J&J Rivaroxaban Product Offered
12.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 J&J Main Business Overview
12.2.5 J&J Latest Developments
...

13 Research Findings and Conclusion

None

None

List of Tables
Table 1. Rivaroxaban Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 2.5 mg
Table 3. Major Players of 10 mg
Table 4. Major Players of 15 mg
Table 5. Major Players of 20 mg
Table 6. Global Rivaroxaban Sales by Type (2016-2021) & (M Units)
Table 7. Global Rivaroxaban Sales Market Share by Type (2016-2021)
Table 8. Global Rivaroxaban Revenue by Type (2016-2021) & ($ million)
Table 9. Global Rivaroxaban Revenue Market Share by Type (2016-2021)
Table 10. Global Rivaroxaban Sale Price by Type (2016-2021)
Table 11. Global Rivaroxaban Sales by Application (2016-2021) & (M Units)
Table 12. Global Rivaroxaban Sales Market Share by Application (2016-2021)
Table 13. Global Rivaroxaban Value by Application (2016-2021)
Table 14. Global Rivaroxaban Revenue Market Share by Application (2016-2021)
Table 15. Global Rivaroxaban Sale Price by Application (2016-2021)
Table 16. Global Rivaroxaban Sales by Company (2019-2021) & (M Units)
Table 17. Global Rivaroxaban Sales Market Share by Company (2019-2021)
Table 18. Global Rivaroxaban Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Rivaroxaban Revenue Market Share by Company (2019-2021)
Table 20. Global Rivaroxaban Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Rivaroxaban Producing Area Distribution and Sales Area
Table 22. Players Rivaroxaban Products Offered
Table 23. Rivaroxaban Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Rivaroxaban Sales by Region (2016-2021) (M Units)
Table 27. Global Rivaroxaban Sales Market Share by Region (2016-2021)
Table 28. Global Rivaroxaban Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Rivaroxaban Revenue Market Share by Region (2016-2021)
Table 30. Americas Rivaroxaban Sales by Country (2016-2021) & (M Units)
Table 31. Americas Rivaroxaban Sales Market Share by Country (2016-2021)
Table 32. Americas Rivaroxaban Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Rivaroxaban Revenue Market Share by Country (2016-2021)
Table 34. Americas Rivaroxaban Sales by Type (2016-2021) & (M Units)
Table 35. Americas Rivaroxaban Sales Market Share by Type (2016-2021)
Table 36. Americas Rivaroxaban Sales by Application (2016-2021) & (M Units)
Table 37. Americas Rivaroxaban Sales Market Share by Application (2016-2021)
Table 38. APAC Rivaroxaban Sales by Region (2016-2021) & (M Units)
Table 39. APAC Rivaroxaban Sales Market Share by Region (2016-2021)
Table 40. APAC Rivaroxaban Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Rivaroxaban Revenue Market Share by Region (2016-2021)
Table 42. APAC Rivaroxaban Sales by Type (2016-2021) & (M Units)
Table 43. APAC Rivaroxaban Sales Market Share by Type (2016-2021)
Table 44. APAC Rivaroxaban Sales by Application (2016-2021) & (M Units)
Table 45. APAC Rivaroxaban Sales Market Share by Application (2016-2021)
Table 46. Europe Rivaroxaban Sales by Country (2016-2021) & (M Units)
Table 47. Europe Rivaroxaban Sales Market Share by Country (2016-2021)
Table 48. Europe Rivaroxaban Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Rivaroxaban Revenue Market Share by Country (2016-2021)
Table 50. Europe Rivaroxaban Sales by Type (2016-2021) & (M Units)
Table 51. Europe Rivaroxaban Sales Market Share by Type (2016-2021)
Table 52. Europe Rivaroxaban Sales by Application (2016-2021) & (M Units)
Table 53. Europe Rivaroxaban Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Rivaroxaban Sales by Country (2016-2021) & (M Units)
Table 55. Middle East & Africa Rivaroxaban Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Rivaroxaban Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Rivaroxaban Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Rivaroxaban Sales by Type (2016-2021) & (M Units)
Table 59. Middle East & Africa Rivaroxaban Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Rivaroxaban Sales by Application (2016-2021) & (M Units)
Table 61. Middle East & Africa Rivaroxaban Sales Market Share by Application (2016-2021)
Table 62. Global Rivaroxaban Sales Forecast by Type (2021-2026) & (M Units)
Table 63. Global Rivaroxaban Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Rivaroxaban Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Rivaroxaban Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Rivaroxaban Sales Forecast by Application (2021-2026) & (M Units)
Table 67. Global Rivaroxaban Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Rivaroxaban Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Rivaroxaban Revenue Market Share Forecast by Application (2021-2026)
Table 70. Bayer Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 71. Bayer Rivaroxaban Product Offered
Table 72. Bayer Rivaroxaban Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 73. Bayer Main Business
Table 74. Bayer Latest Developments
Table 75. J&J Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
Table 76. J&J Rivaroxaban Product Offered
Table 77. J&J Rivaroxaban Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 78. J&J Main Business
Table 79. J&J Latest Developments
List of Figures
Figure 1. Picture of Rivaroxaban
Figure 2. Rivaroxaban Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rivaroxaban Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Rivaroxaban Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Rivaroxaban Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 2.5 mg
Figure 10. Product Picture of 10 mg
Figure 11. Product Picture of 15 mg
Figure 12. Product Picture of 20 mg
Figure 13. Global Rivaroxaban Sales Market Share by Type in 2020
Figure 14. Global Rivaroxaban Revenue Market Share by Type (2016-2021)
Figure 15. Rivaroxaban Consumed in Acute Coronary Syndrome (ACS)
Figure 16. Global Rivaroxaban Market: Acute Coronary Syndrome (ACS) (2016-2021) & (M Units)
Figure 17. Rivaroxaban Consumed in Venous Thromboembolism (VTE)
Figure 18. Global Rivaroxaban Market: Venous Thromboembolism (VTE) (2016-2021) & (M Units)
Figure 19. Global Rivaroxaban Sales Market Share by Application (2016-2021)
Figure 20. Global Rivaroxaban Revenue Market Share by Application in 2020
Figure 21. Global Rivaroxaban Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Rivaroxaban Revenue Market Share by Company in 2020
Figure 23. Global Rivaroxaban Sales Market Share by Regions (2016-2021)
Figure 24. Global Rivaroxaban Revenue Market Share by Region in 2020
Figure 25. Americas Rivaroxaban Sales 2016-2021 (M Units)
Figure 26. Americas Rivaroxaban Revenue 2016-2021 ($ Millions)
Figure 27. APAC Rivaroxaban Sales 2016-2021 (M Units)
Figure 28. APAC Rivaroxaban Revenue 2016-2021 ($ Millions)
Figure 29. Europe Rivaroxaban Sales 2016-2021 (M Units)
Figure 30. Europe Rivaroxaban Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Rivaroxaban Sales 2016-2021 (M Units)
Figure 32. Middle East & Africa Rivaroxaban Revenue 2016-2021 ($ Millions)
Figure 33. Americas Rivaroxaban Sales Market Share by Country in 2020
Figure 34. Americas Rivaroxaban Revenue Market Share by Country in 2020
Figure 35. Americas Rivaroxaban Sales Market Share by Type in 2020
Figure 36. Americas Rivaroxaban Sales Market Share by Application in 2020
Figure 37. United States Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Rivaroxaban Sales Market Share by Region in 2020
Figure 42. APAC Rivaroxaban Revenue Market Share by Regions in 2020
Figure 43. APAC Rivaroxaban Sales Market Share by Type in 2020
Figure 44. APAC Rivaroxaban Sales Market Share by Application in 2020
Figure 45. China Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Rivaroxaban Sales Market Share by Country in 2020
Figure 52. Europe Rivaroxaban Revenue Market Share by Country in 2020
Figure 53. Europe Rivaroxaban Sales Market Share by Type in 2020
Figure 54. Europe Rivaroxaban Sales Market Share by Application in 2020
Figure 55. Germany Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Rivaroxaban Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Rivaroxaban Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Rivaroxaban Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Rivaroxaban Sales Market Share by Application in 2020
Figure 64. Egypt Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Rivaroxaban Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

None

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team